929 results on '"Shao, Zhi-Ming"'
Search Results
2. Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection
3. BOLERO-5: a phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER + /HER2- advanced breast cancer
4. Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF
5. Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy
6. Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
7. Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
8. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients
9. Ipsilateral breast tumor recurrence after breast-conserving surgery: insights into biology and treatment
10. Radiomics in breast cancer: Current advances and future directions
11. Intratumor heterogeneity in breast cancer: Tracing its origins and translating findings into clinical practice
12. Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A
13. DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB
14. Molecular classification of hormone receptor-positive HER2-negative breast cancer
15. Deep learning framework for comprehensive molecular and prognostic stratifications of triple-negative breast cancer
16. Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities
17. Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer
18. Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer
19. Calcifications in triple-negative breast cancer: Molecular features and treatment strategies
20. High expression of TLR3 in triple-negative breast cancer predicts better prognosis—data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays
21. SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches
22. Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial
23. Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low Breast Cancer
24. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
25. CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration
26. Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer
27. Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
28. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria
29. Emerging therapies in cancer metabolism
30. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
31. CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer
32. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials
33. A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer
34. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
35. Artificial intelligence-based diagnosis of breast cancer by mammography microcalcification
36. The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target
37. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
38. Comments on: a prediction model for distant metastasis after isolated locoregional recurrence of breast cancer
39. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
40. O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression
41. A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers
42. Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis
43. Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
44. Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
45. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
46. SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC.
47. Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens
48. Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer
49. Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis
50. Comments on: The clinical relevance of various methods of classifying ipsilateral breast tumor recurrence as either true local recurrence or new primary
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.